A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLC

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(15 sites)

Poland

Centrum Medyczne Pratia, Poznan

Romania

Oncolab S.R.L., Craiova

Spitalul Clinic Municipal de Urgenta Timisoara/ Clinica de Oncologie Medicala, Timișoara

Taiwan

Changhua Christian Hospital (CCH), Changhua

Taipei Tzu Chi Hospital, Chiayi City